<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Malar J</journal-id><journal-id journal-id-type="iso-abbrev">Malar. J</journal-id><journal-title-group><journal-title>Malaria Journal</journal-title></journal-title-group><issn pub-type="epub">1475-2875</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4858840</article-id><article-id pub-id-type="publisher-id">1296</article-id><article-id pub-id-type="doi">10.1186/s12936-016-1296-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Duffy</surname><given-names>Michael F.</given-names></name><address><email>mduffy@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Noviyanti</surname><given-names>Rintis</given-names></name><address><email>rintis@eijkman.go.id</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Tsuboi</surname><given-names>Takafumi</given-names></name><address><email>tsuboi.takafumi.mb@ehime-u.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Zhi-Ping</given-names></name><address><email>feng@wehi.EDU.AU</email></address><xref ref-type="aff" rid="Aff4"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Trianty</surname><given-names>Leily</given-names></name><address><email>leily@eijkman.go.id</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Sebayang</surname><given-names>Boni F.</given-names></name><address><email>boni@eijkman.go.id</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Takashima</surname><given-names>Eizo</given-names></name><address><email>takashima.eizo.mz@ehime-u.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Sumardy</surname><given-names>Fransisca</given-names></name><address><email>fransisca.sumardy@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Lampah</surname><given-names>Daniel A.</given-names></name><address><email>aditimika@yahoo.com</email></address><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Turner</surname><given-names>Louise</given-names></name><address><email>louturn@gmail.com</email></address><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Lavstsen</surname><given-names>Thomas</given-names></name><address><email>thomasl@sund.ku.dk</email></address><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Fowkes</surname><given-names>Freya J. I.</given-names></name><address><email>fowkes@burnet.edu.au</email></address><xref ref-type="aff" rid="Aff8"/></contrib><contrib contrib-type="author"><name><surname>Siba</surname><given-names>Peter</given-names></name><address><email>peter.siba@pngimr.org.pg</email></address><xref ref-type="aff" rid="Aff9"/></contrib><contrib contrib-type="author"><name><surname>Rogerson</surname><given-names>Stephen J.</given-names></name><address><email>sroger@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Theander</surname><given-names>Thor G.</given-names></name><address><email>thor@sund.ku.dk</email></address><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Marfurt</surname><given-names>Jutta</given-names></name><address><email>Jutta.Marfurt@menzies.edu.au</email></address><xref ref-type="aff" rid="Aff10"/></contrib><contrib contrib-type="author"><name><surname>Price</surname><given-names>Ric N.</given-names></name><address><email>rnp@menzies.edu.au</email></address><xref ref-type="aff" rid="Aff10"/><xref ref-type="aff" rid="Aff11"/></contrib><contrib contrib-type="author"><name><surname>Anstey</surname><given-names>Nicholas M.</given-names></name><address><email>Nicholas.Anstey@menzies.edu.au</email></address><xref ref-type="aff" rid="Aff10"/></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Graham V.</given-names></name><address><email>gvb@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff12"/></contrib><contrib contrib-type="author"><name><surname>Papenfuss</surname><given-names>Anthony T.</given-names></name><address><email>papenfuss@wehi.EDU.AU</email></address><xref ref-type="aff" rid="Aff4"/><xref ref-type="aff" rid="Aff5"/><xref ref-type="aff" rid="Aff13"/><xref ref-type="aff" rid="Aff14"/></contrib><aff id="Aff1"><label/>Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria Australia </aff><aff id="Aff2"><label/>The Eijkman Institute for Molecular Biology, Jakarta, Indonesia </aff><aff id="Aff3"><label/>Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime Japan </aff><aff id="Aff4"><label/>Bioinformatics Division, The Walter &#x00026; Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia </aff><aff id="Aff5"><label/>Department of Medical Biology, University of Melbourne, Parkville, Victoria Australia </aff><aff id="Aff6"><label/>Timika Malaria Research Program, Papuan Health and Community Development Foundation, Timika, Papua Indonesia </aff><aff id="Aff7"><label/>Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark </aff><aff id="Aff8"><label/>The Burnet Institute, Melbourne, Victoria Australia </aff><aff id="Aff9"><label/>The Papua New Guinea Institute for Medical Research, Madang, Papua New Guinea </aff><aff id="Aff10"><label/>Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT Australia </aff><aff id="Aff11"><label/>Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK </aff><aff id="Aff12"><label/>The Nossal Institute for Global Health, The University of Melbourne, Parkville, Victoria Australia </aff><aff id="Aff13"><label/>Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia </aff><aff id="Aff14"><label/>Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia </aff></contrib-group><pub-date pub-type="epub"><day>5</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>5</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>15</volume><elocation-id>258</elocation-id><history><date date-type="received"><day>27</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>15</day><month>4</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; Duffy et al. 2016</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p><italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 (PfEMP1) variants are encoded by <italic>var</italic> genes and mediate pathogenic cytoadhesion and antigenic variation in malaria. PfEMP1s can be broadly divided into three principal groups (A, B and C) and they contain conserved arrangements of functional domains called domain cassettes. Despite their tremendous diversity there is compelling evidence that a restricted subset of PfEMP1s is expressed in severe disease. In this study antibodies from patients with severe and uncomplicated malaria were compared for differences in reactivity with a range of PfEMP1s to determine whether antibodies to particular PfEMP1 domains were associated with severe or uncomplicated malaria.</p></sec><sec><title>Methods</title><p>Parts of expressed <italic>var</italic> genes in a severe malaria patient were identified by RNAseq and several of these partial PfEMP1 domains were expressed together with others from laboratory isolates. Antibodies from Papuan patients to these parts of multiple PfEMP1 proteins were measured.</p></sec><sec><title>Results</title><p>Patients with uncomplicated malaria were more likely to have antibodies that recognized PfEMP1 of Group C type and recognized a broader repertoire of group A and B PfEMP1s than patients with severe malaria.</p></sec><sec><title>Conclusion</title><p>These data suggest that exposure to a broad range of group A and B PfEMP1s is associated with protection from severe disease in Papua, Indonesia.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12936-016-1296-4) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Severe malaria</kwd><kwd><italic>var</italic> genes</kwd><kwd>PfEMP1</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>1007954</award-id><award-id>1003856</award-id><award-id>1042072</award-id><award-id>1037304</award-id><principal-award-recipient><name><surname>Duffy</surname><given-names>Michael F.</given-names></name><name><surname>Price</surname><given-names>Ric N.</given-names></name><name><surname>Anstey</surname><given-names>Nicholas M.</given-names></name><name><surname>Papenfuss</surname><given-names>Anthony T.</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>091625</award-id><principal-award-recipient><name><surname>Price</surname><given-names>Ric N.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>PfEMP1 is the immunodominant antigen of the malaria parasite <italic>Plasmodium falciparum</italic> expressed on the surface of the infected erythrocyte (IE). Adherence of this molecule to host receptors expressed on endothelial cells, uninfected erythrocytes and placental syncytiotrophoblasts facilitates sequestration of IE in vascular tissues, avoiding destruction in the spleen [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. PfEMP1 molecules are encoded by the <italic>var</italic> multigene family [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Individual parasites have approximately 60 <italic>var</italic> gene variants and switching between single, transcribed <italic>var</italic> genes leads to changes in cytoadhesive phenotype as well as clonal antigenic variation and immune escape. <italic>var</italic> gene repertoires differ among isolates [<xref ref-type="bibr" rid="CR4">4</xref>] and immunity to malaria is dependent on acquisition of antibodies to a range of PfEMP1 variants [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. Immunity to both cerebral malaria [<xref ref-type="bibr" rid="CR9">9</xref>] and non-cerebral, severe malaria [<xref ref-type="bibr" rid="CR10">10</xref>] is acquired much more rapidly than immunity to uncomplicated malaria. Parasites that cause severe disease appear to express a conserved subset of variant antigens that are encountered earlier in life and that are thus more widely recognized by sera from semi-immune children than parasites causing uncomplicated disease [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p><p>PfEMP1s contain combinations of Duffy binding-like domains (DBL&#x003b1;, &#x003b2;, &#x003b3;, &#x003b4;, &#x003b5;, &#x003b6; and x) and cysteine rich inter-domain regions (CIDR&#x003b1;, &#x003b2;, &#x003b3; and &#x003b4;) [<xref ref-type="bibr" rid="CR13">13</xref>]. Some DBL and CIDR domain subtypes mediate adhesion to different host receptors (reviewed in [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]), and some are organized in semi-conserved domain cassettes (DC) that are present in most parasites [<xref ref-type="bibr" rid="CR4">4</xref>]. <italic>var</italic> genes are also classified using their upstream sequence into groups A, B, C [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] which comprise 20, 60 and 20&#x000a0;% respectively of the <italic>var</italic> gene repertoire [<xref ref-type="bibr" rid="CR4">4</xref>]; the unique <italic>var</italic> gene called <italic>var2csa</italic> has a different upstream sequence (ups E) and is only involved in malaria during pregnancy [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p>The expression of particular subtypes of DBL&#x003b1; domains in severe malaria suggests severe disease may be preferentially caused by a restricted subset of <italic>var</italic> genes [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Increased expression of group A and B <italic>var</italic> genes has been associated with clinical, but not specifically severe malaria in Papua New Guinea (PNG) [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>] and with severe malaria in Africa [<xref ref-type="bibr" rid="CR23">23</xref>]. Cerebral malaria in Africa was associated with increased expression of group A [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] or group B [<xref ref-type="bibr" rid="CR26">26</xref>] <italic>var</italic> genes.</p><p>Consistent with its having a role in severe malaria, PfEMP1s encoded by group A and B <italic>var</italic> genes appear to be widely expressed by parasites that infect non- or semi-immune individuals. Antibodies from older children preferentially recognized PfEMP1s encoded by Group A <italic>var</italic> genes, indicating previous exposure [<xref ref-type="bibr" rid="CR27">27</xref>]. Group A and B <italic>var</italic> genes dominated infection of a naive individual [<xref ref-type="bibr" rid="CR28">28</xref>], and more individuals develop antibodies to group A PfEMP1s than group B or C, and do so at a younger age [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p>Group A and B <italic>var</italic> genes also encode adhesion phenotypes associated with severe disease. In Africa the adhesion phenotype of rosetting is associated with severe malaria [<xref ref-type="bibr" rid="CR14">14</xref>] and increased expression of group A <italic>var</italic> genes [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Some group A and B PfEMP1s can bind to intercellular adhesion molecule 1 (ICAM-1) [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], and ICAM-1 expression was up-regulated in brain endothelium and co-localized with sequestered IEs in cerebral malaria patients [<xref ref-type="bibr" rid="CR32">32</xref>]. IE adhesion to ICAM-1 has variously been associated with cerebral malaria [<xref ref-type="bibr" rid="CR33">33</xref>], clinical but not severe malaria [<xref ref-type="bibr" rid="CR34">34</xref>] or inversely correlated with severe disease [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p>Another phenotype associated with severe disease is adhesion to endothelial protein C receptor, EPCR [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Parasite isolates from African children with severe malaria bound EPCR and expressed DC8 or DC13 <italic>var</italic> genes [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. DC8 and DC13 PfEMP1s are primarily group B and A, respectively [<xref ref-type="bibr" rid="CR4">4</xref>], and contain members of the subset of CIDR&#x003b1;1 domain types, which bind EPCR [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Sera from African children with uncomplicated malaria recognize PfEMP1s containing DC8 and DC13 at higher levels than PfEMP1s without DC8 or 13, but it is unclear whether severe malaria specifically induces antibodies to DC8 and DC13 [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>].</p><p>DC5 PfEMP1s, which are nearly all group A, are recognized by sera from semi-immune children in a similar manner to other severe malaria associated isolates [<xref ref-type="bibr" rid="CR27">27</xref>], and DC5 expression increased markedly during infection of a naive volunteer [<xref ref-type="bibr" rid="CR41">41</xref>]. African children acquired antibodies to DC5 more rapidly than to other PfEMP1 domains which is consistent with widespread expression of DC5 in non-immune individuals [<xref ref-type="bibr" rid="CR29">29</xref>]. Antibodies reactive with DC5 also correlated with protection from malaria episodes [<xref ref-type="bibr" rid="CR42">42</xref>]; however, the evidence directly linking DC5 PfEMP1 expression and adhesion phenotype to severe malaria is less clear. High levels of DC5 sequence expression have been detected in severe malaria, but only together with expression of either DC8 or 13 sequences [<xref ref-type="bibr" rid="CR38">38</xref>] and it is conceivable that these DC5 and DC8 or DC13 sequences were present on the same <italic>var</italic> genes. DC5 PfEMP1s bind platelet-endothelial cell adhesion molecule 1 (PECAM1) [<xref ref-type="bibr" rid="CR43">43</xref>] and IE adhesion to PECAM1 has been implicated in cerebral malaria [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. However, IE adhesion to PECAM1 is also commonly found in samples from patients with uncomplicated malaria [<xref ref-type="bibr" rid="CR46">46</xref>] and DC5 PfEMP1s were not expressed by parasites selected for adhesion to brain endothelium [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. A minority of <italic>var</italic> genes containing DC5 do encode EPCR-binding CIDR&#x003b1;1.5 domains although these domains are not part of the DC5 cassette [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p>Thus several promising candidates have emerged as members of the restricted population of PfEMP1s responsible for severe malaria, but the relative contributions of group A and B, and of DCs 8, 13 and 5 remain unclear. In particular very little is known about PfEMP1s in severe disease in the Asia Pacific region. Determining whether conserved PfEMP1sequences elicit protection from severe malaria disease globally is a priority for vaccine research. In this study plasmas from Papuan patients with severe or uncomplicated malaria were analysed for their reactivity with PfEMP1 polypeptides representative of the different groups and DCs including several expressed by parasites causing cerebral malaria.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Methods</title><sec id="Sec3"><title>Patient samples</title><p>Two ml of venous blood was collected from a 5-year old female patient with cerebral malaria in PNG. The IEs were separated from white blood cells by Plasmodipur column filtration (Europroxima) as per the manufacturer&#x02019;s instructions. The IEs were lysed in TRIzol<sup><bold>&#x000ae;</bold></sup> (Life Technologies), incubated at 37&#x000a0;&#x000b0;C for 5&#x000a0;min and then stored at &#x02212;80&#x000a0;&#x000b0;C. Venous samples were collected from patients with severe (n&#x000a0;=&#x000a0;28) and uncomplicated (n&#x000a0;=&#x000a0;35) malaria attending a healthcare facility in Timika, Papua Province, Indonesia. Plasma was separated from blood by centrifugation and stored at &#x02212;20&#x000a0;&#x000b0;C. This area has unstable malaria transmission with estimated annual parasite incidence of 450 per 1000 population and symptomatic illness in all ages [<xref ref-type="bibr" rid="CR47">47</xref>]. Severe malaria was defined as peripheral parasitaemia with at least one modified World Health Organization (WHO) criterion of severity [<xref ref-type="bibr" rid="CR48">48</xref>]. Twenty-six of the 28 patients with severe malaria had parasitemias greater than 1000/&#x003bc;L, which is a previously-derived threshold that predicts clinical disease in northern Papua [<xref ref-type="bibr" rid="CR49">49</xref>]. Thus incidental parasitemia is unlikely in these 26 severe malaria patients but cannot be excluded in the two severe malaria patients with parasitemias less than 1000/&#x003bc;l.</p></sec><sec id="Sec4"><title>Ethics</title><p>Informed consent was provided by all participants. The study was approved in Indonesia by the Eijkman Institute Research Ethics Commission (project number 46), in Australia by the Melbourne Health Human Research Ethics Committee (project number 2010.284) and Human Research Ethics Committee of the NT Department of Health &#x00026; Families and Menzies School of Health Research, Darwin, Australia (HREC 2010&#x02013;1396), and in PNG by the Government of PNG Medical Research Advisory Committee (MRAC no. 11.12).</p></sec><sec id="Sec5"><title>RNA extraction and RNAseq</title><p>Erythrocytes in TRIzol<sup><bold>&#x000ae;</bold></sup> were thawed at 37&#x000a0;&#x000b0;C, chloroform (1/5th of the TRIzol<sup><bold>&#x000ae;</bold></sup> volume) was added and vortexed 15&#x000a0;s, the solution was then subjected to centrifugation at 12,000&#x000d7;g for 30&#x000a0;min at 4&#x000a0;&#x000b0;C and the aqueous supernatant was aspirated and mixed with an equal volume of 70&#x000a0;% ethanol in RNase free water. This solution was then directly applied to RNeasy mini columns (QIAGEN), and RNA purification was performed with on-column DNasing as per the manufacturer&#x02019;s instructions. Eluted RNA was oligo dT purified and used to generate a 65&#x000a0;bp paired end RNAseq library using the standard Illumina protocol. The library was sequenced on an Illumina GAII at Geneworks (Adelaide).</p><p>Alignments were performed using Subreads [<xref ref-type="bibr" rid="CR50">50</xref>]. Reads were first aligned to the 399 full length <italic>var</italic> genes that were previously described in seven <italic>P. falciparum</italic> isolates [<xref ref-type="bibr" rid="CR4">4</xref>] and mapped reads were extracted. Reads were also aligned to the 3D7 <italic>P. falciparum</italic> genome and unmapped reads were extracted to include any <italic>var</italic> that may have been missed. The reads that mapped to <italic>var</italic> genes and the reads that did not map to the 3D7 genome were then merged, digitally normalized using khmer [<xref ref-type="bibr" rid="CR51">51</xref>], and assembled using Oases [<xref ref-type="bibr" rid="CR52">52</xref>]. Assembled transcripts were subjected to a second round of <italic>de novo</italic> assembly using Cap3 [<xref ref-type="bibr" rid="CR53">53</xref>] to assemble contigs and extract consensus sequences from the contigs. Contigs were aligned to the domains from the 399 <italic>var</italic> genes with BLAST (version 2.2.25). The transcript abundance was determined by aligning the reads again to the assembled transcripts.</p></sec><sec id="Sec6"><title>Protein expression</title><p>Proteins for Luminex assays were expressed in baculovirus-transfected insect cells as previously described [<xref ref-type="bibr" rid="CR54">54</xref>]. Proteins analysed by Luminex were IT4var02 protein 1 DBL&#x003b3;12DBL&#x003b4;5CIDR&#x003b2;3DBL&#x003b2;9, PF11_0008 DBL&#x003b4;5CIDR&#x003b2;4, IT4var02 protein 2 DBL&#x003b4;5CIDR&#x003b2;3, HB3var05 DC16 DBL&#x003b1;1.6CIDR&#x003b4;1, PFI1820w var3 DBL&#x003b1;1.3 DBL&#x003b5;8, PFD0020c DBL&#x003b2;12 DBL&#x003b3;6, IT4var20 DBL&#x003b1;2CIDR&#x003b1;1.1DBL&#x003b2;12DBL&#x003b3;6DBL&#x003b4;1CIDR&#x003b2;1, PF11_0007 DBL&#x003b1;0.15CIDR&#x003b1;3.2DBL&#x003b4;1CIDR&#x003b2;1, PFL0020w DBL&#x003b3;14DBL&#x003b6;5DBL&#x003b5;4, IT4var13 DC 9 DBL&#x003b1;0.3CIDR&#x003b1;5DBL&#x003b2;5DBL&#x003b4;9CIDR&#x003b3;9DBL&#x003b3;11DBL&#x003b6;4.</p><p>PfEMP1 domains identified by RNAseq as expressed by the parasites infecting the PNG CM patient were amplified from gDNA purified from the patient&#x02019;s blood for use as ELISA antigens. The sequences were then cloned into the plasmid pEU-E01H-N1 (encoding an N terminal His-tagged protein; CellFree Sciences Matsuyama, Japan) [<xref ref-type="bibr" rid="CR55">55</xref>] and expressed in the wheat germ cell-free expression system (CellFree Sciences) and purified on Ni-nitrilotriacetic acid agarose columns (Qiagen, Valencia, CA) as previously described [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>].</p><p>Antigens used for the ELISA included proteins one to seven that were encoded by <italic>var</italic> gene sequences transcribed by parasites infecting the cerebral malaria patient from PNG. Proteins 1 and 3 were encoded by 352&#x000a0;bp and&#x000a0;123&#x000a0;bp fragments of a contig with homology to the DC5 DBL&#x003b2;7_D8 of Dd2var4 (ranked 33rd by transcript abundance) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Protein 2 was encoded by a 861&#x000a0;bp orthologue of DC5 DBL&#x003b4;5_D6_Dd2var4 that incorporated two contigs that were ranked 4th and 9th by abundance (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Protein 4 was encoded by a 697&#x000a0;bp fragment of a contig with homology to a DC8 DBL&#x003b3;6_D3_Dd2var47 (ranked 5th by abundance). Protein 5 was encoded by a 186&#x000a0;bp fragment with homology to DBL&#x003b3;10 of raj116 and was ranked 34th by abundance. Protein 6 was encoded by a 425&#x000a0;bp contig that incorporated two non-overlapping contigs with homology to NTSB3_DBL&#x003b1;0.11 of igh_var31 and DBL&#x003b1;0.15 of raj116_var34 (ranked respectively14th and 21st by abundance). Protein 7 was a 142&#x000a0;bp cloned orthologue of DBL&#x003b4;1<bold>_</bold>D4_PFCLIN_var24 (ranked 96th by abundance).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>
<italic>var</italic> sequences transcribed by parasites infecting a Papua New Guinean cerebral malaria patient</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">
<italic>var</italic> Homologs<sup>a, b</sup>
</th><th align="left">Notes</th><th align="left">RPK<sup>c</sup>
</th><th align="left">Contig bp</th><th align="left">Homology bp</th><th align="left">E value</th><th align="left">% Identity</th></tr></thead><tbody><tr><td align="left">CIDR&#x003b1;2.4_D3_MAL7P1.55</td><td align="left"/><td char="." align="char">7384</td><td char="." align="char">425</td><td align="left">131</td><td align="left">5.44E&#x02212;34</td><td align="left">84</td></tr><tr><td align="left">DBL&#x003b4;1_D4_ighvar31_CIDR&#x003b3;9_D5_ighvar35</td><td align="left"/><td char="." align="char">5174</td><td char="." align="char">1553</td><td align="left">133, 410</td><td align="left">2.52E&#x02212;32, 1E&#x02212;100</td><td align="left">82.7, 79</td></tr><tr><td align="left">DBL&#x003b4;9_D5_PFCLINvar74</td><td align="left"/><td char="." align="char">4369</td><td char="." align="char">583</td><td align="left">303</td><td align="left">1.05E&#x02212;44</td><td align="left">76.2</td></tr><tr><td align="left">
<italic>DBL&#x003b4;5_D6_Dd2var4</italic>
</td><td align="left">DC5 ELISA protein 2</td><td char="." align="char">4227</td><td char="." align="char">273</td><td align="left">219</td><td align="left">1.19E&#x02212;52</td><td align="left">80.4</td></tr><tr><td align="left">
<italic>DBL&#x003b3;6_D3_DD2var47&#x02013;DBL&#x003b3;2_D5_DD2var42</italic>
</td><td align="left">DC8 ELISA protein 4</td><td char="." align="char">4130</td><td char="." align="char">1807</td><td align="left">190, 488</td><td align="left">2.57E&#x02212;58, 6.86E&#x02212;148</td><td align="left">86.3, 85</td></tr><tr><td align="left">DBL&#x003b2;6_D5_igh_var27</td><td align="left"/><td char="." align="char">3562</td><td char="." align="char">395</td><td align="left">258</td><td align="left">3.17E&#x02212;68</td><td align="left">81.8</td></tr><tr><td align="left">DBL&#x003b5;1_D6_PFCLINvar76</td><td align="left">var1csa</td><td char="." align="char">3340</td><td char="." align="char">1025</td><td align="left">429</td><td align="left">0</td><td align="left">100</td></tr><tr><td align="left">CIDR&#x003b1;3.1_D3_DD2var50</td><td align="left"/><td char="." align="char">2973</td><td char="." align="char">550</td><td align="left">86.1</td><td align="left">3.24E&#x02212;57</td><td align="left">86.1</td></tr><tr><td align="left">
<italic>DBL&#x003b4;5_D6_Dd2var4</italic>
</td><td align="left">DC5 ELISA protein 2</td><td char="." align="char">2891</td><td char="." align="char">156</td><td align="left">123</td><td align="left">7.29E&#x02212;46</td><td align="left">92.7</td></tr><tr><td align="left">CIDR&#x003b2;1_D8_HB3var1</td><td align="left"/><td char="." align="char">2814</td><td char="." align="char">650</td><td align="left">161</td><td align="left">7.44E&#x02212;41</td><td align="left">82.6</td></tr><tr><td align="left">CIDR&#x003b1;3.1 pf08&#x02013;0106&#x02013;DBL&#x003b4;5_D5_igh_var30</td><td align="left"/><td char="." align="char">2302</td><td char="." align="char">883</td><td align="left">167, 310</td><td align="left">1.51E&#x02212;38, 7.32E&#x02212;68</td><td align="left">85.6, 80.6</td></tr><tr><td align="left">DBL&#x003b3;15_D5_PFCLINvar76 (var1csa)</td><td align="left"/><td char="." align="char">2199</td><td char="." align="char">246</td><td align="left">230</td><td align="left">2.56E&#x02212;117</td><td align="left">100</td></tr><tr><td align="left">DBL&#x003b3;17_D4_DD2var43&#x02013;DBL&#x003b4;5_D5_HB3var2</td><td align="left">DC5</td><td char="." align="char">2153</td><td char="." align="char">626</td><td align="left">192, 250</td><td align="left">4.51E&#x02212;56, 4.23E&#x02212;31</td><td align="left">87.5, 73.6</td></tr><tr><td align="left">
<italic>NTSB3_D1_igh_var31</italic>&#x02013;<italic>DBL&#x003b1;0.11_D2_AAB60251</italic>
</td><td align="left">ELISA protein 6</td><td char="." align="char">2085</td><td char="." align="char">189</td><td align="left">93, 80</td><td align="left">1.03E&#x02212;19, 1.03E&#x02212;19</td><td align="left">81.7, 85</td></tr><tr><td align="left">DBL&#x003b3;10_D5_HB3var34</td><td align="left">DC17,21,22</td><td char="." align="char">1994</td><td char="." align="char">344</td><td align="left">193</td><td align="left">2.94E&#x02212;74</td><td align="left">91.7</td></tr><tr><td align="left">CIDR&#x003b2;1_D7_raj116_var11</td><td align="left">DC8</td><td char="." align="char">1980</td><td char="." align="char">606</td><td align="left">408</td><td align="left">1.98E&#x02212;60</td><td align="left">73.8</td></tr><tr><td align="left">DBL&#x003b2;1_D4_igh_var19</td><td align="left">DC8</td><td char="." align="char">1935</td><td char="." align="char">402</td><td align="left">344</td><td align="left">1.29E&#x02212;98</td><td align="left">83.7</td></tr><tr><td align="left">DBL&#x003b4;1_D4_HB3var50</td><td align="left"/><td char="." align="char">1911</td><td char="." align="char">302</td><td align="left">229</td><td align="left">3.32E&#x02212;60</td><td align="left">82.1</td></tr><tr><td align="left">DBL&#x003b4;1_D4_IT4var39</td><td align="left"/><td char="." align="char">1894</td><td char="." align="char">216</td><td align="left">203</td><td align="left">2.31E&#x02212;41</td><td align="left">76.4</td></tr><tr><td align="left">DBL&#x003b2;6_D4_igh_var9</td><td align="left"/><td char="." align="char">1883</td><td char="." align="char">437</td><td align="left">251</td><td align="left">3.1E&#x02212;75</td><td align="left">85.3</td></tr><tr><td align="left">
<italic>DBL&#x003b1;0.15_D2_raj116_var34</italic>
</td><td align="left">ELISA protein 6</td><td char="." align="char">1871</td><td char="." align="char">132</td><td align="left">125</td><td align="left">6.84E&#x02212;39</td><td align="left">87.2</td></tr><tr><td align="left">DBL&#x003b4;1_D4_IT4var46&#x02013;DBL&#x003b3;4_D5_raj116_var11</td><td align="left"/><td char="." align="char">1867</td><td char="." align="char">1461</td><td align="left">115, 258</td><td align="left">4.57E&#x02212;35, 3.5E&#x02212;106</td><td align="left">87.8, 84.1</td></tr><tr><td align="left">DBL&#x003b1;0.1_D2_HB3var30</td><td align="left"/><td char="." align="char">1846</td><td char="." align="char">338</td><td align="left">215</td><td align="left">5.37E&#x02212;43</td><td align="left">82.8</td></tr><tr><td align="left">DBL&#x003b3;6_D5_IT4var32b</td><td align="left">DC8</td><td char="." align="char">1833</td><td char="." align="char">307</td><td align="left">178</td><td align="left">1.45E&#x02212;49</td><td align="left">83.7</td></tr><tr><td align="left">DBL&#x003b3;13_D5_HB3var21</td><td align="left"/><td char="." align="char">1822</td><td char="." align="char">828</td><td align="left">402</td><td align="left">1.09E&#x02212;114</td><td align="left">90.7</td></tr><tr><td align="left">CIDR&#x003b2;4_dd2var22&#x02013;DBL&#x003b2;3_D4_HB3var3</td><td align="left">DC5-multi domain contig</td><td char="." align="char">1819</td><td char="." align="char">1152</td><td align="left">707, 339</td><td align="left">3.35E&#x02212;86, 1.34E&#x02212;59</td><td align="left">70.9, 75.2</td></tr><tr><td align="left">CIDR&#x003b1;2.9_D3_raj116_var14&#x000a0;&#x02013;DBL&#x003b4;1_D6_IT4var32b</td><td align="left"/><td char="." align="char">1741</td><td char="." align="char">534</td><td align="left">43, 196</td><td align="left">1.83E&#x02212;15, 9.49E&#x02212;32</td><td align="left">100, 76</td></tr><tr><td align="left">DBL&#x003b1;0.19_D2_Itvar66-CIDR&#x003b1;2.4_D3_raj116_var29</td><td align="left"/><td char="." align="char">1729</td><td char="." align="char">410</td><td align="left">96, 279</td><td align="left">3.33E&#x02212;36, 2.73E&#x02212;56</td><td align="left">93.8, 79.2</td></tr><tr><td align="left">DBL&#x003b4;1_D4_igh_var20</td><td align="left"/><td char="." align="char">1724</td><td char="." align="char">480</td><td align="left">237</td><td align="left">5.43E&#x02212;57</td><td align="left">79.7</td></tr><tr><td align="left">DBL&#x003b4;1_D4_IT4var47</td><td align="left"/><td char="." align="char">1714</td><td char="." align="char">263</td><td align="left">172</td><td align="left">3.28E&#x02212;46</td><td align="left">83.7</td></tr><tr><td align="left">DBL&#x003b4;1_D4_igh_var18</td><td align="left"/><td char="." align="char">1696</td><td char="." align="char">289</td><td align="left">227</td><td align="left">2.78E&#x02212;48</td><td align="left">82.8</td></tr><tr><td align="left">DBL&#x003b4;1_D4_PFD1005c</td><td align="left"/><td char="." align="char">1649</td><td char="." align="char">191</td><td align="left">191</td><td align="left">5.39E&#x02212;36</td><td align="left">76.9</td></tr><tr><td align="left">
<italic>DBL&#x003b2;7_D8_Dd2var4</italic>
</td><td align="left">DC5 ELISA proteins 1 &#x00026; 3</td><td char="." align="char">1644</td><td char="." align="char">859</td><td align="left">793</td><td align="left">1.46E&#x02212;152</td><td align="left">78.6</td></tr><tr><td align="left">
<italic>DBL&#x003b3;10_D4_PFCLINvar71</italic>
</td><td align="left">ELISA protein 5</td><td char="." align="char">1587</td><td char="." align="char">511</td><td align="left">204</td><td align="left">2.3E&#x02212;71</td><td align="left">89.2</td></tr><tr><td align="left">DBL&#x003b2;5_D4_IT4var16-DBL&#x003b4;1_D4_raj116_var32</td><td align="left"/><td char="." align="char">1579</td><td char="." align="char">447</td><td align="left">135, 62</td><td align="left">5.743E&#x02212;53, 1.11E&#x02212;17</td><td align="left">93.3, 90.3</td></tr><tr><td align="left">DBL&#x003b4;1_D4_raj116_var29</td><td align="left"/><td char="." align="char">1573</td><td char="." align="char">309</td><td align="left">297</td><td align="left">2.3E&#x02212;43</td><td align="left">73.4</td></tr><tr><td align="left">DBL&#x003b2;12_D4_raj116_var11&#x02013;DBL&#x003b3;11_D4_raj116_var17</td><td align="left"/><td char="." align="char">1534</td><td char="." align="char">712</td><td align="left">215, 178</td><td align="left">7.05E&#x02212;47, 1.45E&#x02212;36</td><td align="left">79.5, 80.3</td></tr><tr><td align="left">DBL&#x003b2;11_D4_IT4var35&#x02013;DBL&#x003b3;3_D7_HB3var4</td><td align="left"/><td char="." align="char">1520</td><td char="." align="char">931</td><td align="left">163, 131</td><td align="left">3.27E&#x02212;65, 3.5E&#x02212;33</td><td align="left">93.3, 83.2</td></tr><tr><td align="left">DBL&#x003b5;3_D8_raj116_var29</td><td align="left"/><td char="." align="char">1508</td><td char="." align="char">179</td><td align="left">60</td><td align="left">3.63E&#x02212;25</td><td align="left">100</td></tr><tr><td align="left">DBL&#x003b4;1_D7_IT4var22</td><td align="left"/><td char="." align="char">1454</td><td char="." align="char">388</td><td align="left">351</td><td align="left">6.02E&#x02212;52</td><td align="left">74.1</td></tr><tr><td align="left">DBL&#x003b4;1_D5_igh_var5</td><td align="left"/><td char="." align="char">1438</td><td char="." align="char">281</td><td align="left">287</td><td align="left">1.07E&#x02212;40</td><td align="left">70.5</td></tr><tr><td align="left">DBL&#x003b2;3_D4_AAQ73927&#x02013;DBL&#x003b3;4_D5_raj116_var8</td><td align="left"/><td char="." align="char">1428</td><td char="." align="char">458</td><td align="left">171, 184</td><td align="left">8.18E&#x02212;45, 2.2E&#x02212;39</td><td align="left">83, 79.9</td></tr><tr><td align="left">DBL&#x003b5;10_D8_IT4var4</td><td align="left"/><td char="." align="char">1392</td><td char="." align="char">442</td><td align="left">138</td><td align="left">3.35E&#x02212;43</td><td align="left">87.7</td></tr><tr><td align="left">DBL&#x003b4;1_D4_PFCLINvar28 (var2csa)</td><td align="left"/><td char="." align="char">1378</td><td char="." align="char">506</td><td align="left">138</td><td align="left">9.7E&#x02212;51</td><td align="left">91.3</td></tr><tr><td align="left">DBL&#x003b3;8_D7_PFCLINvar76 (var1csa)</td><td align="left"/><td char="." align="char">1377</td><td char="." align="char">244</td><td align="left">200</td><td align="left">1.05E&#x02212;71</td><td align="left">92</td></tr><tr><td align="left">DBL&#x003b3;11_D5_DD2var52&#x02013;DBL&#x003b4;1_D4_PFCLINvar36</td><td align="left"/><td char="." align="char">1351</td><td char="." align="char">910</td><td align="left">322, 84</td><td align="left">3.21E&#x02212;47, 1.12E&#x02212;27</td><td align="left">73.6, 91.7</td></tr><tr><td align="left">DBL&#x003b1;1.6_D2_DD2var22</td><td align="left"/><td char="." align="char">1320</td><td char="." align="char">111</td><td align="left">102</td><td align="left">1.7E&#x02212;26</td><td align="left">84.3</td></tr><tr><td align="left">DBL&#x003b1;0.15_D2_HB3var18</td><td align="left"/><td char="." align="char">1298</td><td char="." align="char">352</td><td align="left">306</td><td align="left">1.28E&#x02212;53</td><td align="left">77.8</td></tr><tr><td align="left">CIDR&#x003b2;1_D8_IT4var22</td><td align="left"/><td char="." align="char">1297</td><td char="." align="char">431</td><td align="left">224</td><td align="left">9.97E&#x02212;69</td><td align="left">89.7</td></tr><tr><td align="left">CIDR&#x003b1;1.5_D3_ighvar30&#x02013;DBL&#x003b2;7_D7_PFCLINvar69</td><td align="left">EPCR binding</td><td char="." align="char">1283</td><td char="." align="char">2183</td><td align="left">(31, 42, 66), 681</td><td align="left">(1.06E&#x02212;3, 3.7E&#x02212;3, 1.21E&#x02212;15), 1.33E&#x02212;110</td><td align="left">(87.1, 90.5, 98.5), 73.6</td></tr></tbody></table><table-wrap-foot><p>Shown are the 50 highest-ranked transcripts</p><p>
<sup>a</sup>The domains that were expressed for analysis by ELISA are in italics</p><p>
<sup>b</sup>Domain annotation is as per [<xref ref-type="bibr" rid="CR4">4</xref>]: domain subtype_domain (D) position within the PfEMP1 numbered from the most N terminal DBL/CIDR domain_<italic>P. falciparum</italic> isolate name <italic>var</italic> gene name</p><p>
<sup>c</sup>The transcripts are ordered by coverage [reads mapped per kb assembled transcript (rpk)]</p></table-wrap-foot></table-wrap></p><p>Proteins 1, 2 and 3 were most closely related to the DC5 domain <italic>var</italic> gene Dd2var4. This gene has group A-like coding features, e.g. head structure and ATS, and is the only DC5 with a group B-like upstream sequence, the other 11 all being group A [<xref ref-type="bibr" rid="CR4">4</xref>]. Therefore, proteins 1, 2 and 3 were classified as group A for all subsequent analyses. These PNG derived proteins were supplemented by domains from HB3, 3D7 and ItG parasites that included two DBL&#x003b4; domains from group C PfEMP1s, a DC8 CIDR&#x003b1;1.1, a DC13 CIDR&#x003b1;1.4 and a CIDR&#x003b1;3.1 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b).</p></sec><sec id="Sec7"><title>Serology</title><p>The Luminex assay was performed as previously described [<xref ref-type="bibr" rid="CR54">54</xref>]. For each protein an eleven point standard curve was made using two-fold dilutions of pooled positive plasma starting with 1/40, which was assigned an arbitrary value of 1000 relative units (RU). Plasmas were diluted in 0.02&#x000a0;% Tween-20, 0.1&#x000a0;% BSA in PBS pH 7.4. Fluorescent intensities of patients&#x02019; plasmas were used to interpolate antibody concentrations in RU from the standard curves.</p><p>ELISA was performed as previously described [<xref ref-type="bibr" rid="CR54">54</xref>]. ELISA plates were blocked with 3&#x000a0;% (w/v) skim milk in PBS and all antibodies were diluted with 1&#x000a0;% (w/v) skim milk in PBS. Each plate included a pool of positive plasmas that was diluted two fold from 1/50 to 1/800 to generate a five point standard curve. The 1/50 dilution of pooled positive plasma was assigned an arbitrary value of 800 relative units (RU). All plasmas were tested at 1/50 and OD values interpolated from the standard curve for that plate. Any plasma that were below the curve were assigned the lowest value, any that were above the curve were re-tested at two-fold dilutions from 1/50 to 1/400. A pool of unexposed donor plasma at the same dilution as the test plasmas was included as a negative control in every Luminex and ELISA assay.</p></sec></sec><sec id="Sec8"><title>Statistical analyses</title><p>The association between disease severity with age and parasitaemia was assessed using a Mann&#x02013;Whitney <italic>U</italic>-test and with gender using a Fisher&#x02019;s exact test. RU values for individual proteins were compared by Mann&#x02013;Whitney <italic>U</italic>-test. To compare between patients with severe and uncomplicated malaria for antibody responses to proteins belonging to a single domain cassette or PfEMP1 group, patients were categorized according to whether their plasma sample lay above or below the median concentration of RU for that antigen: those above or equal scoring 1, or 0 if below. To derive a single quantitative score for each plasma for all the proteins belonging to a single DC or PfEMP1 group, the plasma&#x02019;s scores for each antigen in that DC or group that were determined by either Luminex or ELISA were summed.</p><p>Any individual plasma with a score of 1 for any protein within a DC or PfEMP1 group was classified as a responder to that DC or PfEMP1. Individual plasma samples with a combined score of 0 for all proteins within a DC or group were classified as non-responders.</p><p>Differences in the proportions of severe and uncomplicated malaria patients whose plasma responded to a DC or PfEMP1 group were compared by contingency tables using Fisher&#x02019;s exact test. Differences between severe and uncomplicated malaria patients in the number of proteins within a DC or PfEMP1 group to which patients responded were compared only for patients who responded to at least one protein in the DC or PfEMP1 group using Mann&#x02013;Whitney <italic>U</italic>- tests. This indicated differences in the breadth of the response to PfEMP1s within that group. The patients that did not respond to any protein within the group, i.e. had a score of zero were not included to remove any biases associated with large frequencies of zero values in non-parametric comparisons [<xref ref-type="bibr" rid="CR57">57</xref>].</p></sec><sec id="Sec9" sec-type="results"><title>Results</title><sec id="Sec10"><title><italic>Var</italic> genes expressed in a Papua New Guinean cerebral malaria patient</title><p>To identify <italic>var</italic> sequences transcribed by parasites infecting this patient we used Illumina RNAseq to generate 65&#x000a0;bp paired-end short reads. Reads that mapped to the 399 full length <italic>var</italic> gene sequences available [<xref ref-type="bibr" rid="CR4">4</xref>] were merged with reads that did not map to the <italic>P. falciparum</italic> 3D7 strain genome nor <italic>Homo sapiens</italic>, and the merged reads were subjected to two rounds of <italic>de novo</italic> assembly to generate 623 contigs that included 362 contigs with homology to <italic>var</italic> genes. The total length of assembled contigs was 200,158&#x000a0;bp, N50 423&#x000a0;bp, maximum contig length 4083&#x000a0;bp. The short contig length allowed assembly of only a few, full domains. However, the contigs could be aligned by BLASTN (E value&#x000a0;&#x0003c;10<sup>&#x02212;5</sup>) to individual domains from the 399 full-length <italic>var</italic> genes and orthologs of high identity to annotated domains and DC types were identified (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).</p><p>We compared the percentage of reads from the patient that assembled in transcripts with homology to domain subtypes with the percentage of total <italic>var</italic> exon 1 sequence in the seven sequenced <italic>P. falciparum</italic> genomes that each domain subtype represented. DBL&#x003b4;1, NTSB, CIDR&#x003b2;1, NTSA and CIDR&#x003b1;3.1 were all abundant transcripts but also constituted a similar proportion of <italic>var</italic> transcripts as the proportion of total <italic>var</italic> exon1 sequences they constitute in the seven sequenced genomes (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Therefore, their abundance could represent random <italic>var</italic> gene transcription. Other abundant transcripts (present at more than 10&#x000a0;% of the level of total DBL&#x003b4;1) but which were transcribed at more than three times their level of representation in the seven sequenced genomes included DBL&#x003b3;6, 4, 9, and 10, DBL&#x003b4;5, DBL&#x003b2;6 and 7, CIDR&#x003b1;2.4, CIDRb2 and DBL&#x003b5;1 and 6 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>The sequence reads from the parasites infecting a cerebral malaria patient that assembled to different PfEMP1 domain subtypes normalized for domain size and expressed as a percentage of all reads that assembled to <italic>var</italic> contigs. Also shown is the percentage of total PfEMP1 domains that each domain subtype constituted in the seven sequenced <italic>P. falciparum</italic> genomes. Domains are ordered by transcript abundance</p></caption><graphic xlink:href="12936_2016_1296_Fig1_HTML" id="MO1"/></fig></p><p>The abundance of individual transcripts was compared using reads mapped per kb of assembled contiguous transcript (RPK) (see &#x0201c;<xref rid="Sec2" ref-type="sec">Methods</xref>&#x0201d; section). The most abundant individual transcripts included a diverse range of CIDR and DBL domains. The first and eighth most abundant transcripts were CIDR&#x003b1;2.4 and CIDR&#x003b1;3.1 sequences that could potentially bind CD36 [<xref ref-type="bibr" rid="CR58">58</xref>] (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The second and third most abundant transcripts had no previous associations with severe disease or conserved domain cassettes. The fourth and the ninth most abundant were DC5 associated DBL&#x003b4;5 sequences, 12 of the 13 published DBL&#x003b4;5 sequences are present in DC5 genes. The 13th and 26th most abundant transcripts were also unique DC5 tandem-domain arrangements of DBL&#x003b3;17-DBL&#x003b4;5 and CIDR&#x003b2;4-DBL&#x003b2;3, respectively.</p><p>The most promising candidates for causing severe malaria are the EPCR-binding CIDR&#x003b1;1 domains of DC8 and DC13 PfEMP1s. The most abundant CIDR&#x003b1;1 capable of EPCR binding [<xref ref-type="bibr" rid="CR36">36</xref>] in this patient was a CIDR&#x003b1;1.5-DBL&#x003b2;7 contig ranked 50th overall by abundance. All described DC8s have a unique DBL&#x003b1;2-CIDR&#x003b1;1.1/1.6/1.8 tandem domain arrangement [<xref ref-type="bibr" rid="CR4">4</xref>], but the most abundant DBL&#x003b1;2 was ranked 102nd by abundance. Four of the 50 most abundant transcripts had greatest homology to domains found in DC8 PfEMP1s (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Thus DC8 <italic>var</italic> genes may have been abundantly expressed by the parasites infecting this patient however these domains are also found at least as frequently in non-DC8 PfEMP1s. The DC13 is characterized by the tandem array of a DBL&#x003b1;1.7-CIDR&#x003b1;1.4 but neither of these domains were abundantly transcribed in this patient.</p><p><italic>Var1csa</italic> sequences were the 7th, 12th and 45th most abundant transcripts; expression of this gene was not previously observed to be elevated in severe disease [<xref ref-type="bibr" rid="CR59">59</xref>] and it is ubiquitously transcribed [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>], atypically late in the cell cycle after transcription of <italic>var</italic> genes encoding the adhesion phenotype [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. The 26th, 42nd and 35th most abundant transcripts were two DBL&#x003b2;3 and a DBL&#x003b2;5, respectively. DBL&#x003b2;5 and some DBL&#x003b2;3 including those in DC4 have been shown to bind ICAM-1 [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. DBL&#x003b5;10 from <italic>var2csa</italic> was the 43<sup>rd</sup> most abundant transcript. No other DCs were identified in the 50 most abundant transcripts.</p></sec><sec id="Sec11"><title>Patterns of PfEMP1 antibody reactivity in severe and uncomplicated malaria in Papua</title><p>Antibody reactivity with PfEMP1 was assessed in plasma from 28 patients with severe malaria (median years 29, IQR 18.5-34; median <italic>P. falciparum</italic> parasites/&#x000b5;l 41,220, IQR 8260-334,273; 61&#x000a0;% male) and 35 patients with uncomplicated malaria (median years 22.5, IQR 18.0-25.5,; median <italic>P. falciparum</italic> parasites/&#x000b5;l 27,680, IQR 16,800-52,800; 54&#x000a0;% male). Patients with severe malaria tended to be older than those with uncomplicated malaria (<italic>p</italic>&#x000a0;=&#x000a0;0.0599), but there was no significant difference in <italic>P. falciparum</italic> density (<italic>p</italic>&#x000a0;=&#x000a0;0.7288) and gender (<italic>p</italic>&#x000a0;=&#x000a0;0.7981). Twenty-three patients with severe malaria had a single diagnostic criterion (WHO) [<xref ref-type="bibr" rid="CR48">48</xref>], including five with cerebral malaria, six with jaundice, eight with hyperparasitaemia, three with prostration, and one with acute renal failure. Five patients had two or more manifestations of severe malaria: one patient with jaundice and prostration, one with acute renal failure and acute respiratory distress syndrome, one with jaundice and hyperparasitaemia, and two with jaundice and acute renal failure.</p><p>To examine the reactivity of Papuan patient plasma with different PfEMP1 groups and DCs previously associated with severe or uncomplicated disease we tested 10 PfEMP1 DCs and the non-PfEMP1 proteins GLURP and MSP3 by a Luminex multiplexed bead assay; and twelve recombinant, partial PfEMP1 domains by ELISA. The proteins tested included groupings previously associated with severe disease (DC8, DC13, DC5, group A and group B) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Individual datapoints for all plasmas and all antigens tested are presented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Levels of antibodies to PfEMP1s in plasma from 28 patients with severe malaria and 35 patients with uncomplicated malaria, RU (Relative units-see &#x0201c;<xref rid="Sec2" ref-type="sec">Methods</xref>&#x0201d; section). Whiskers are minimum and maximum values, <sup>#</sup>
<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.1, *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01. <bold>a</bold> Proteins assayed by Luminex; <bold>b</bold> Proteins assayed by ELISA; &#x000a7; insufficient of the DBL&#x003b2;7 group A3 DC5 domain was available to test the full repertoire of plasma so it was only tested against 20 plasma from severe malaria patients, and was omitted from subsequent analyses</p></caption><graphic xlink:href="12936_2016_1296_Fig2_HTML" id="MO2"/></fig></p><p>The DC domain constructs used in the Luminex assay were derived from the 3D7, ItG and HB3 isolates. Seven of the proteins used for ELISA were derived from sequences transcribed in the PNG cerebral malaria patient described above and included abundantly transcribed (by RPK) representatives of DC5 DBL&#x003b2;7, DC5 DBL&#x003b4;5, DC8 DBL&#x003b3;6 and DBL&#x003b3;10 (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>; Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b and see &#x0201c;<xref rid="Sec2" ref-type="sec">Methods</xref>&#x0201d; section for details). These domain subtypes were all transcribed at more than threefold their level of representation in the seven sequenced genomes (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). The most abundantly transcribed representative of the conserved NTS-DBL&#x003b1; arrangement was also included as well as a less abundant DBLd1 transcript (protein 7) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>; Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b). By Luminex assay, levels of antibodies to MSP3 but not GLURP were higher in plasma from patients with uncomplicated malaria than in severe malaria, (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a) (median MSP3 22 versus 11 RU, respectively, <italic>p</italic>&#x000a0;=&#x000a0;0.055). The MSP3 data suggests that patients with uncomplicated malaria may have had more prior exposure to <italic>P. falciparum</italic> infection than the patients with severe malaria.</p><p>In the Luminex assay, patients with uncomplicated malaria generally had higher levels of antibody to individual PfEMP1s than patients with severe disease, the greatest difference being in a DC16 PfEMP1 (p&#x000a0;=&#x000a0;0.0095) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). Interestingly DC16 are group A PfEMP1s that have been shown not to be associated with severe disease [<xref ref-type="bibr" rid="CR38">38</xref>]. For four proteins, there was no significant difference (all <italic>p</italic>&#x000a0;&#x0003e;&#x000a0;0.054) in antibody response between plasma from patients with severe and uncomplicated malaria. These proteins included three severe malaria-associated PfEMP1s, two DC5, and one DC8 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a).</p><p>In the ELISA, patients with uncomplicated malaria had significantly higher levels of antibody than patients with severe malaria to two group C PfEMP1s that were from lab isolates and a single group B DBL&#x003b3; from the cerebral malaria patient (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b; <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). A non-significant trend in the same direction (<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.10) was observed for a single DC5 and a single DC8.</p><p>The combined results for the ELISA and the Luminex assays revealed that a greater proportion of the patients with uncomplicated malaria than with severe malaria had antibodies to group C PfEMP1s (<italic>p</italic>&#x000a0;=&#x000a0;0.004) and to PfEMP1s that were not DC5, nor 8, nor 13 (<italic>p</italic>&#x000a0;=&#x000a0;0.008) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a). While the proportion of plasma reactive with severe malaria-associated proteins was higher in individuals with uncomplicated compared to severe malaria, the magnitude of the difference was smaller and not statistically significant (all <italic>p</italic>&#x000a0;&#x0003e;&#x000a0;0.194). It is possible that analysing larger numbers of proteins in these groupings on a single platform may have detected differences.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>
<bold>a</bold> The proportion of plasmas from patients with severe and uncomplicated malaria that had a response to a PfEMP1 group or DC (responders had greater than or equal to the median level of of antibody for all plasmas with at least one protein within the PfEMP1 group or DC-see &#x0201c;<xref rid="Sec2" ref-type="sec">Methods</xref> section&#x0201d;) (Fisher&#x02019;s exact test). <bold>b</bold> Amongst responders only, the number of proteins within a group or DC for which a response was detected, whiskers are minimum/maximum values, <sup>#</sup>p&#x000a0;&#x0003c;&#x000a0;0.1, *p&#x000a0;&#x0003c;&#x000a0;0.05, **p&#x000a0;&#x0003c;&#x000a0;0.01</p></caption><graphic xlink:href="12936_2016_1296_Fig3_HTML" id="MO3"/></fig></p><p>Amongst patients with an antibody response to at least one protein of a cassette or group, plasma from patients with uncomplicated malaria recognized more PfEMP1s overall, and more group A and group B PfEMP1s than did plasma from patients with severe malaria (<italic>p</italic>&#x000a0;=&#x000a0;0.031, <italic>p</italic>&#x000a0;=&#x000a0;0.044 and <italic>p</italic>&#x000a0;=&#x000a0;0.014, respectively, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b). Thus although similar proportions of patients with severe and uncomplicated malaria had been exposed to at least one group A or group B PfEMP1 (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a), the breadth of responses to the group A and group B PfEMP1s tested was lower in patients with severe malaria.</p></sec></sec><sec id="Sec12" sec-type="discussion"><title>Discussion</title><p>Sequencing the transcriptome of parasites causing CM in a single patient enabled assembly of a snapshot of the transcribed <italic>var</italic> repertoire in human malaria. Although entire genes could not be assembled, advances in the phylogenetics of <italic>var</italic> sequences [<xref ref-type="bibr" rid="CR4">4</xref>] allowed the <italic>var</italic> contigs to be separated into useful classifications. Previous studies that implicated parasites expressing group A PfEMP1s [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>] and group B PfEMP1s [<xref ref-type="bibr" rid="CR26">26</xref>] in severe disease provided no, or minimal, sequence data and were essentially restricted to classifying sequences to the groups defined by the <italic>var</italic> gene upstream sequences or by sequencing short DBL&#x003b1; tags.</p><p>The RNAseq of parasites causing CM in this PNG patient was consistent with previous studies of <italic>var</italic> genes in pathogenesis and abundantly expressed <italic>var</italic> genes identified included DC5 and possibly DC8, the DBL&#x003b2;3 domain subtype and individual domains including CIDR&#x003b1;1.5 and DBL&#x003b2;3. Recombinant proteins derived from the latter two domain subtypes have been shown to bind EPCR and ICAM-1 respectively [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Other abundantly transcribed domain subtypes had not previously been identified in severe malaria. This limited study of a single patient indicates that RNAseq will be useful for identifying quantitative differences between transcribed <italic>var</italic> genes in severe disease in future studies.</p><p>The diversity of the transcribed <italic>var</italic> repertoire was consistent with a previous report of cerebral malaria in Africa [<xref ref-type="bibr" rid="CR65">65</xref>]. However, 45&#x000a0;% of the reads that assembled into <italic>var</italic> transcripts were in the 20 most abundant <italic>var</italic> contigs that between them represented 27 domains. Thus the quantitative nature of RNAseq revealed a hierarchy of <italic>var</italic> transcript abundance in this patient&#x02019;s peripheral blood that would be difficult to detect using the non-quantitative, nested RT-PCR approaches available to this previous study [<xref ref-type="bibr" rid="CR65">65</xref>]. This suggests that the dominant <italic>var</italic> transcripts expressed by parasites causing cerebral malaria in a single patient are probably restricted in number.</p><p>Patients with uncomplicated malaria more commonly had antibodies to PfEMP1s that were from Group C or were not from DC5 nor DC8 nor DC13 than patients with severe malaria (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a). In contrast, similar proportions of patients with severe and uncomplicated malaria had developed antibodies to the severe malaria associated PfEMP1s (group A and B, DC5, 8 and 13) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a), but the breadth of the response to group A and B PfEMP1s was greater in patients with uncomplicated than severe disease (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b). Thus susceptibility to severe disease was associated with recognition of a narrower range of group A and B PfEMP1s and to an overall lack of antibodies to group C PfEMP1s and to PfEMP1s that were not DC5 nor DC8 nor DC13.</p><p>Overall, the serology findings in this Papuan adult population are consistent with existing models of infection in African children where parasites expressing severe malaria-associated group A and B PfEMP1s infect naive individuals and elicit antibodies [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Susceptible, semi-immune individuals have antibody to some group A and B PfEMP1s [<xref ref-type="bibr" rid="CR27">27</xref>], but protective immunity correlates with acquisition of antibodies recognizing a broader range of PfEMP1s [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. Parasites expressing uncomplicated disease associated group C PfEMP1s, or PfEMP1s that were not DC5, 8 nor 13, would only dominate infections after parasites expressing severe disease associated PfEMP1s were controlled by acquisition of a broad antibody response. The alternative explanation is that group C PfEMP1s and PfEMP1s that were not DC5, 8 nor 13 were abundantly expressed by parasites causing acute, severe malaria but had not yet elicited antibodies. Although this cannot be excluded it is inconsistent with previous studies of <italic>var</italic> gene expression in both Africa and PNG [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec13" sec-type="conclusion"><title>Conclusion</title><p>In Papuan adults severe malaria is associated with a lack of antibodies to non-DC5 and 8 and group C PfEMP1s in general, and with antibodies to a narrower repertoire of group A and group B PfEMP1s than in patients with uncomplicated malaria. These findings from Papua are consistent with reports from Africa of elevated group A and B <italic>var</italic> gene expression in severe disease [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>] and of earlier development of antibodies to group A PfEMP1s in children [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. This study has also established the feasibility of performing RNAseq on patient isolates to identify expressed <italic>var</italic> gene sequences.</p></sec></body><back><app-group><app id="App1"><sec id="Sec14"><title>Additional file</title><p><media position="anchor" xlink:href="12936_2016_1296_MOESM1_ESM.eps" id="MOESM1"><caption><p>
10.1186/s12936-016-1296-4 Levels of antibodies to PfEMP1s in plasma from 28 patients with severe malaria and 35 patients with uncomplicated malaria, RU (Relative Units-see materials and methods). Median values are indicated by red bars and negative control pooled plasmas from unexposed donors by red dots, <sup>#</sup>
<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.1, *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01. A) Proteins assayed by Luminex; B) Proteins assayed by ELISA; &#x000a7; insufficient of the DBL&#x003b2;7 group A3 DC5 domain was available to test the full repertoire of plasma so it was only tested against 20 plasma from severe malaria patients, and was omitted from subsequent analyses.</p></caption></media></p></sec></app></app-group><ack><title>Authors&#x02019; contributions</title><p>MFD conceived the study, performed molecular, serological and bioinformatic analyses and drafted the manuscript. RN helped design the study, designed and organized sample collection and performed molecular studies. TT and ET expressed recombinant proteins. BSF and LT organized sample collection and performed molecular studies. JM, DAL, RNP and NMA helped design the study and organized sample collection. FS performed molecular studies. LT, TL and TG helped design the study, expressed proteins and designed serological analyses. FJIF performed statistical analyses. ZPF performed bioinformatic analyses. SJR and GVB helped design the study and draft the manuscript. PS helped organize sample collection. ATP helped design the study and performed bioinformatic analyses. All authors read and approved the final manuscript.</p><sec id="FPar1"><title>Acknowledgements</title><p>We would like to thank all patients and their families from Papua Province, Indonesia, and Papua New Guinea for participating in the study. We acknowledge Laurens Manning for help in collecting patient samples. This work was supported by National Health and Medical Research Council of Australia [Grant 1007954, Grant 513782, Career Development Fellowship to ATP (1003856) and Practitioner Fellowship to NMA (1042072). The Timika Research Facility and Papuan Community Health Foundation were supported by AusAID (Australian Agency for International Development, Department of Foreign Affairs and Trade) and the National Health and Medical Research Council of Australia (Program Grant 1037304 awarded to RNP and NMA) and the Wellcome Trust (Senior Fellowship in Clinical Science 091625 awarded to RNP). The work benefitted from support by the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.</p></sec><sec id="FPar2"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baruch</surname><given-names>DI</given-names></name><name><surname>Pasloske</surname><given-names>BL</given-names></name><name><surname>Singh</surname><given-names>HB</given-names></name><name><surname>Bi</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>XC</given-names></name><name><surname>Feldman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cloning the <italic>P. falciparum</italic> gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes</article-title><source>Cell</source><year>1995</year><volume>82</volume><fpage>77</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90054-3</pub-id><?supplied-pmid 7541722?><pub-id pub-id-type="pmid">7541722</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Chitnis</surname><given-names>CE</given-names></name><name><surname>Craig</surname><given-names>AG</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Hudson-Taylor</surname><given-names>DE</given-names></name><name><surname>Peterson</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Switches in expression of <italic>Plasmodium falciparum</italic><italic>var</italic> genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes</article-title><source>Cell</source><year>1995</year><volume>82</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90056-X</pub-id><?supplied-pmid 7606775?><pub-id pub-id-type="pmid">7606775</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>XZ</given-names></name><name><surname>Heatwole</surname><given-names>VM</given-names></name><name><surname>Wertheimer</surname><given-names>SP</given-names></name><name><surname>Guinet</surname><given-names>F</given-names></name><name><surname>Herrfeldt</surname><given-names>JA</given-names></name><name><surname>Peterson</surname><given-names>DS</given-names></name><etal/></person-group><article-title>The large diverse gene family <italic>var</italic> encodes proteins involved in cytoadherence and antigenic variation of <italic>Plasmodium falciparum</italic>-infected erythrocytes</article-title><source>Cell</source><year>1995</year><volume>82</volume><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90055-1</pub-id><?supplied-pmid 7606788?><pub-id pub-id-type="pmid">7606788</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rask</surname><given-names>TS</given-names></name><name><surname>Hansen</surname><given-names>DA</given-names></name><name><surname>Theander</surname><given-names>TG</given-names></name><name><surname>Pedersen</surname><given-names>AG</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name></person-group><article-title><italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 diversity in seven genomes&#x02014;divide and conquer</article-title><source>PLoS Comput Biol</source><year>2010</year><volume>6</volume><fpage>e1000933</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000933</pub-id><?supplied-pmid 20862303?><pub-id pub-id-type="pmid">20862303</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Otoo</surname><given-names>L</given-names></name><name><surname>Hayes</surname><given-names>RJ</given-names></name><name><surname>Carson</surname><given-names>DC</given-names></name><name><surname>Greenwood</surname><given-names>BM</given-names></name></person-group><article-title>Antibodies to blood stage antigens of <italic>Plasmodium falciparum</italic> in rural Gambians and their relation to protection against infection</article-title><source>Trans R Soc Trop Med Hyg</source><year>1989</year><volume>83</volume><fpage>293</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(89)90478-1</pub-id><?supplied-pmid 2694458?><pub-id pub-id-type="pmid">2694458</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newbold</surname><given-names>CI</given-names></name><name><surname>Pinches</surname><given-names>R</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name></person-group><article-title><italic>Plasmodium falciparum</italic>: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific</article-title><source>Exp Parasitol</source><year>1992</year><volume>75</volume><fpage>281</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/0014-4894(92)90213-T</pub-id><?supplied-pmid 1426131?><pub-id pub-id-type="pmid">1426131</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>JA</given-names></name><name><surname>Howell</surname><given-names>KB</given-names></name><name><surname>Reiling</surname><given-names>L</given-names></name><name><surname>Ataide</surname><given-names>R</given-names></name><name><surname>Mackintosh</surname><given-names>CL</given-names></name><name><surname>Fowkes</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Targets of antibodies against <italic>Plasmodium falciparum</italic>-infected erythrocytes in malaria immunity</article-title><source>J Clin Invest.</source><year>2012</year><volume>122</volume><fpage>3227</fpage><lpage>3238</lpage><pub-id pub-id-type="doi">10.1172/JCI62182</pub-id><?supplied-pmid 22850879?><pub-id pub-id-type="pmid">22850879</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Howard</surname><given-names>RJ</given-names></name></person-group><article-title>Antigens induced on erythrocytes by <italic>P. falciparum</italic>: expression of diverse and conserved determinants</article-title><source>Science</source><year>1986</year><volume>231</volume><fpage>150</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1126/science.2417315</pub-id><?supplied-pmid 2417315?><pub-id pub-id-type="pmid">2417315</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Snow</surname><given-names>RW</given-names></name><name><surname>Donnelly</surname><given-names>C</given-names></name><name><surname>Newbold</surname><given-names>C</given-names></name></person-group><article-title>Acquired immunity and postnatal clinical protection in childhood cerebral malaria</article-title><source>Proc Biol Sci.</source><year>1999</year><volume>266</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1098/rspb.1999.0600</pub-id><?supplied-pmid 10081156?><pub-id pub-id-type="pmid">10081156</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Snow</surname><given-names>RW</given-names></name></person-group><article-title>C.A. D, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections</article-title><source>Nature Med.</source><year>1999</year><volume>5</volume><fpage>340</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1038/6560</pub-id><?supplied-pmid 10086393?><pub-id pub-id-type="pmid">10086393</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bull</surname><given-names>PC</given-names></name><name><surname>Kortok</surname><given-names>M</given-names></name><name><surname>Kai</surname><given-names>O</given-names></name><name><surname>Ndungu</surname><given-names>F</given-names></name><name><surname>Ross</surname><given-names>A</given-names></name><name><surname>Lowe</surname><given-names>BS</given-names></name><etal/></person-group><article-title><italic>Plasmodium falciparum</italic>-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age</article-title><source>J Infect Dis</source><year>2000</year><volume>182</volume><fpage>252</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1086/315652</pub-id><?supplied-pmid 10882604?><pub-id pub-id-type="pmid">10882604</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>MA</given-names></name><name><surname>Staalsoe</surname><given-names>T</given-names></name><name><surname>Kurtzhals</surname><given-names>JA</given-names></name><name><surname>Goka</surname><given-names>BQ</given-names></name><name><surname>Dodoo</surname><given-names>D</given-names></name><name><surname>Alifrangis</surname><given-names>M</given-names></name><etal/></person-group><article-title><italic>Plasmodium falciparum</italic> variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity</article-title><source>J Immunol.</source><year>2002</year><volume>168</volume><fpage>3444</fpage><lpage>3450</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.168.7.3444</pub-id><?supplied-pmid 11907103?><pub-id pub-id-type="pmid">11907103</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Subramanian</surname><given-names>G</given-names></name><name><surname>Gamain</surname><given-names>B</given-names></name><name><surname>Baruch</surname><given-names>DI</given-names></name><name><surname>Miller</surname><given-names>LH</given-names></name></person-group><article-title>Classification of adhesive domains in the <italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 family</article-title><source>Mol Biochem Parasitol</source><year>2000</year><volume>110</volume><fpage>293</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/S0166-6851(00)00279-6</pub-id><?supplied-pmid 11071284?><pub-id pub-id-type="pmid">11071284</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowe</surname><given-names>JA</given-names></name><name><surname>Claessens</surname><given-names>A</given-names></name><name><surname>Corrigan</surname><given-names>RA</given-names></name><name><surname>Arman</surname><given-names>M</given-names></name></person-group><article-title>Adhesion of <italic>Plasmodium falciparum</italic>-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications</article-title><source>Expert Rev Mol Med</source><year>2009</year><volume>11</volume><fpage>e16</fpage><pub-id pub-id-type="doi">10.1017/S1462399409001082</pub-id><?supplied-pmid 19467172?><pub-id pub-id-type="pmid">19467172</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Rowe</surname><given-names>JA</given-names></name><name><surname>Higgins</surname><given-names>MK</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name></person-group><article-title>Malaria&#x02019;s deadly grip: cytoadhesion of <italic>Plasmodium falciparum</italic>-infected erythrocytes</article-title><source>Cell Microbiol</source><year>2013</year><volume>15</volume><fpage>1976</fpage><lpage>1983</lpage><pub-id pub-id-type="doi">10.1111/cmi.12183</pub-id><?supplied-pmid 23957661?><pub-id pub-id-type="pmid">23957661</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>MJ</given-names></name><name><surname>Hall</surname><given-names>N</given-names></name><name><surname>Fung</surname><given-names>E</given-names></name><name><surname>White</surname><given-names>O</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Hyman</surname><given-names>RW</given-names></name><etal/></person-group><article-title>Genome sequence of the human malaria parasite <italic>Plasmodium falciparum</italic></article-title><source>Nature</source><year>2002</year><volume>419</volume><fpage>498</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/nature01097</pub-id><?supplied-pmid 12368864?><pub-id pub-id-type="pmid">12368864</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Salanti</surname><given-names>A</given-names></name><name><surname>Jensen</surname><given-names>AT</given-names></name><name><surname>Arnot</surname><given-names>DE</given-names></name><name><surname>Theander</surname><given-names>TG</given-names></name></person-group><article-title>Sub-grouping of <italic>Plasmodium falciparum</italic> 3D7 <italic>var</italic> genes based on sequence analysis of coding and non-coding regions</article-title><source>Malar J.</source><year>2003</year><volume>2</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-2-27</pub-id><?supplied-pmid 14565852?><pub-id pub-id-type="pmid">14565852</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salanti</surname><given-names>A</given-names></name><name><surname>Staalsoe</surname><given-names>T</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Jensen</surname><given-names>AT</given-names></name><name><surname>Sowa</surname><given-names>MP</given-names></name><name><surname>Arnot</surname><given-names>DE</given-names></name><etal/></person-group><article-title>Selective upregulation of a single distinctly structured <italic>var</italic> gene in chondroitin sulphate A-adhering <italic>Plasmodium falciparum</italic> involved in pregnancy-associated malaria</article-title><source>Mol Microbiol</source><year>2003</year><volume>49</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03570.x</pub-id><?supplied-pmid 12823820?><pub-id pub-id-type="pmid">12823820</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Normark</surname><given-names>J</given-names></name><name><surname>Nilsson</surname><given-names>D</given-names></name><name><surname>Ribacke</surname><given-names>U</given-names></name><name><surname>Winter</surname><given-names>G</given-names></name><name><surname>Moll</surname><given-names>K</given-names></name><name><surname>Wheelock</surname><given-names>CE</given-names></name><etal/></person-group><article-title>PfEMP1-DBL1alpha amino acid motifs in severe disease states of <italic>Plasmodium falciparum</italic> malaria</article-title><source>Proc Natl Acad</source><year>2007</year><volume>104</volume><fpage>15835</fpage><lpage>15840</lpage><pub-id pub-id-type="doi">10.1073/pnas.0610485104</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warimwe</surname><given-names>GM</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Fegan</surname><given-names>G</given-names></name><name><surname>Musyoki</surname><given-names>JN</given-names></name><name><surname>Newton</surname><given-names>CR</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><etal/></person-group><article-title><italic>Plasmodium falciparum var</italic> gene expression is modified by host immunity</article-title><source>Proc Natl Acad Sci</source><year>2009</year><volume>106</volume><fpage>21801</fpage><lpage>21806</lpage><pub-id pub-id-type="doi">10.1073/pnas.0907590106</pub-id><?supplied-pmid 20018734?><pub-id pub-id-type="pmid">20018734</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaestli</surname><given-names>M</given-names></name><name><surname>Cockburn</surname><given-names>IA</given-names></name><name><surname>Cortes</surname><given-names>A</given-names></name><name><surname>Baea</surname><given-names>K</given-names></name><name><surname>Rowe</surname><given-names>JA</given-names></name><name><surname>Beck</surname><given-names>HP</given-names></name></person-group><article-title>Virulence of malaria is associated with differential expression of <italic>Plasmodium falciparum var</italic> gene subgroups in a case-control study</article-title><source>J Infect Dis</source><year>2006</year><volume>193</volume><fpage>1567</fpage><lpage>1574</lpage><pub-id pub-id-type="doi">10.1086/503776</pub-id><?supplied-pmid 16652286?><pub-id pub-id-type="pmid">16652286</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname><given-names>N</given-names></name><name><surname>Kaestli</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>W</given-names></name><name><surname>Ott</surname><given-names>M</given-names></name><name><surname>Baea</surname><given-names>K</given-names></name><name><surname>Cortes</surname><given-names>A</given-names></name><etal/></person-group><article-title>Analysis of <italic>Plasmodium falciparum var</italic> genes expressed in children from Papua New Guinea</article-title><source>J Infect Dis</source><year>2009</year><volume>200</volume><fpage>347</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1086/600071</pub-id><?supplied-pmid 19552523?><pub-id pub-id-type="pmid">19552523</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rottmann</surname><given-names>M</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Mugasa</surname><given-names>JP</given-names></name><name><surname>Kaestli</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>AT</given-names></name><name><surname>Muller</surname><given-names>D</given-names></name><etal/></person-group><article-title>Differential expression of <italic>var</italic> gene groups is associated with morbidity caused by <italic>Plasmodium falciparum</italic> infection in Tanzanian children</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><fpage>3904</fpage><lpage>3911</lpage><pub-id pub-id-type="doi">10.1128/IAI.02073-05</pub-id><?supplied-pmid 16790763?><pub-id pub-id-type="pmid">16790763</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyriacou</surname><given-names>HM</given-names></name><name><surname>Stone</surname><given-names>GN</given-names></name><name><surname>Challis</surname><given-names>RJ</given-names></name><name><surname>Raza</surname><given-names>A</given-names></name><name><surname>Lyke</surname><given-names>KE</given-names></name><name><surname>Thera</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Differential <italic>var</italic> gene transcription in <italic>Plasmodium falciparum</italic> isolates from patients with cerebral malaria compared to hyperparasitaemia</article-title><source>Mol Biochem Parasitol</source><year>2006</year><volume>150</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1016/j.molbiopara.2006.08.005</pub-id><?supplied-pmid 16996149?><pub-id pub-id-type="pmid">16996149</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warimwe</surname><given-names>GM</given-names></name><name><surname>Fegan</surname><given-names>G</given-names></name><name><surname>Musyoki</surname><given-names>JN</given-names></name><name><surname>Newton</surname><given-names>CR</given-names></name><name><surname>Opiyo</surname><given-names>M</given-names></name><name><surname>Githinji</surname><given-names>G</given-names></name><etal/></person-group><article-title>Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles</article-title><source>Sci Transl Med.</source><year>2012</year><volume>4</volume><fpage>129</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3003247</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalmbach</surname><given-names>Y</given-names></name><name><surname>Rottmann</surname><given-names>M</given-names></name><name><surname>Kombila</surname><given-names>M</given-names></name><name><surname>Kremsner</surname><given-names>PG</given-names></name><name><surname>Beck</surname><given-names>HP</given-names></name><name><surname>Kun</surname><given-names>JF</given-names></name></person-group><article-title>Differential var gene expression in children with malaria and antidromic effects on host gene expression</article-title><source>J Infect Dis</source><year>2010</year><volume>202</volume><fpage>313</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1086/653586</pub-id><?supplied-pmid 20540611?><pub-id pub-id-type="pmid">20540611</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>AT</given-names></name><name><surname>Magistrado</surname><given-names>P</given-names></name><name><surname>Sharp</surname><given-names>S</given-names></name><name><surname>Joergensen</surname><given-names>L</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Chiucchiuini</surname><given-names>A</given-names></name><etal/></person-group><article-title><italic>Plasmodium falciparum</italic> associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A <italic>var</italic> genes</article-title><source>J Exp Med</source><year>2004</year><volume>199</volume><fpage>1179</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1084/jem.20040274</pub-id><?supplied-pmid 15123742?><pub-id pub-id-type="pmid">15123742</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CW</given-names></name><name><surname>Hermsen</surname><given-names>CC</given-names></name><name><surname>Sauerwein</surname><given-names>RW</given-names></name><name><surname>Arnot</surname><given-names>DE</given-names></name><name><surname>Theander</surname><given-names>TG</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name></person-group><article-title>The <italic>Plasmodium falciparum var</italic> gene transcription strategy at the onset of blood stage infection in a human volunteer</article-title><source>Parasitol Int</source><year>2009</year><volume>58</volume><fpage>478</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.parint.2009.07.004</pub-id><?supplied-pmid 19616120?><pub-id pub-id-type="pmid">19616120</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cham</surname><given-names>GK</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Lusingu</surname><given-names>J</given-names></name><name><surname>Vestergaard</surname><given-names>L</given-names></name><name><surname>Mmbando</surname><given-names>BP</given-names></name><name><surname>Kurtis</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Sequential, ordered acquisition of antibodies to <italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 domains</article-title><source>J Immunol.</source><year>2009</year><volume>183</volume><fpage>3356</fpage><lpage>3363</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901331</pub-id><?supplied-pmid 19675168?><pub-id pub-id-type="pmid">19675168</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>DP</given-names></name><name><surname>Levin</surname><given-names>EA</given-names></name><name><surname>Springer</surname><given-names>AL</given-names></name><name><surname>Kraemer</surname><given-names>SM</given-names></name><name><surname>Phippard</surname><given-names>DJ</given-names></name><name><surname>Schief</surname><given-names>WR</given-names></name><etal/></person-group><article-title>Mapping a common interaction site used by <italic>Plasmodium falciparum</italic> duffy binding-like domains to bind diverse host receptors</article-title><source>Mol Microbiol</source><year>2008</year><volume>67</volume><fpage>78</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.06019.x</pub-id><?supplied-pmid 18047571?><pub-id pub-id-type="pmid">18047571</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oleinikov</surname><given-names>AV</given-names></name><name><surname>Amos</surname><given-names>E</given-names></name><name><surname>Frye</surname><given-names>IT</given-names></name><name><surname>Rossnagle</surname><given-names>E</given-names></name><name><surname>Mutabingwa</surname><given-names>TK</given-names></name><name><surname>Fried</surname><given-names>M</given-names></name><etal/></person-group><article-title>High throughput functional assays of the variant antigen PfEMP1 reveal a single domain in the 3D7 <italic>Plasmodium falciparum</italic> genome that binds ICAM1 with high affinity and is targeted by naturally acquired neutralizing antibodies</article-title><source>PLoS Pathog</source><year>2009</year><volume>5</volume><fpage>e1000386</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000386</pub-id><?supplied-pmid 19381252?><pub-id pub-id-type="pmid">19381252</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>GDH</given-names></name><name><surname>Morrison</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>TME</given-names></name><name><surname>Looareesuwan</surname><given-names>S</given-names></name><name><surname>Buley</surname><given-names>ID</given-names></name><etal/></person-group><article-title>An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration</article-title><source>Am J Pathol</source><year>1994</year><volume>145</volume><fpage>1057</fpage><lpage>1069</lpage><?supplied-pmid 7526692?><pub-id pub-id-type="pmid">7526692</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochola</surname><given-names>LB</given-names></name><name><surname>Siddondo</surname><given-names>BR</given-names></name><name><surname>Ocholla</surname><given-names>H</given-names></name><name><surname>Nkya</surname><given-names>S</given-names></name><name><surname>Kimani</surname><given-names>EN</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name><etal/></person-group><article-title>Specific receptor usage in <italic>Plasmodium falciparum</italic> cytoadherence is associated with disease outcome</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e14741</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0014741</pub-id><?supplied-pmid 21390226?><pub-id pub-id-type="pmid">21390226</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newbold</surname><given-names>C</given-names></name><name><surname>Warn</surname><given-names>P</given-names></name><name><surname>Black</surname><given-names>G</given-names></name><name><surname>Berendt</surname><given-names>A</given-names></name><name><surname>Craig</surname><given-names>A</given-names></name><name><surname>Snow</surname><given-names>B</given-names></name><etal/></person-group><article-title>Receptor-specific adhesion and clinical disease in <italic>Plasmodium falciparum</italic></article-title><source>Am J Trop Med Hyg</source><year>1997</year><volume>57</volume><fpage>389</fpage><lpage>398</lpage><?supplied-pmid 9347951?><pub-id pub-id-type="pmid">9347951</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogerson</surname><given-names>SJ</given-names></name><name><surname>Tembenu</surname><given-names>R</given-names></name><name><surname>Dobano</surname><given-names>C</given-names></name><name><surname>Plitt</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>TE</given-names></name><name><surname>Molyneux</surname><given-names>ME</given-names></name></person-group><article-title>Cytoadherence characteristics of <italic>Plasmodium falciparum</italic>-infected erythrocytes from Malawian children with severe and uncomplicated malaria</article-title><source>Am J Trop Med Hyg</source><year>1999</year><volume>61</volume><fpage>467</fpage><lpage>472</lpage><?supplied-pmid 10497992?><pub-id pub-id-type="pmid">10497992</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Berger</surname><given-names>SS</given-names></name><name><surname>Wang</surname><given-names>CW</given-names></name><name><surname>Petersen</surname><given-names>JE</given-names></name><name><surname>Avril</surname><given-names>M</given-names></name><etal/></person-group><article-title>Severe malaria is associated with parasite binding to endothelial protein C receptor</article-title><source>Nature</source><year>2013</year><volume>498</volume><fpage>502</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1038/nature12216</pub-id><?supplied-pmid 23739325?><pub-id pub-id-type="pmid">23739325</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>CK</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Jespersen</surname><given-names>JS</given-names></name><name><surname>Lowe</surname><given-names>ED</given-names></name><name><surname>Petersen</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>CW</given-names></name><etal/></person-group><article-title>Structural conservation despite huge sequence diversity allows EPCR binding by the PfEMP1 family implicated in severe childhood malaria</article-title><source>Cell Host Microbe</source><year>2015</year><volume>17</volume><fpage>118</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.11.007</pub-id><?supplied-pmid 25482433?><pub-id pub-id-type="pmid">25482433</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Saguti</surname><given-names>F</given-names></name><name><surname>Magistrado</surname><given-names>P</given-names></name><name><surname>Rask</surname><given-names>TS</given-names></name><name><surname>Jespersen</surname><given-names>JS</given-names></name><etal/></person-group><article-title><italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children</article-title><source>Proc Natl Acad Sci</source><year>2012</year><volume>109</volume><fpage>E1791</fpage><lpage>E1800</lpage><pub-id pub-id-type="doi">10.1073/pnas.1120455109</pub-id><?supplied-pmid 22619319?><pub-id pub-id-type="pmid">22619319</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avril</surname><given-names>M</given-names></name><name><surname>Tripathi</surname><given-names>AK</given-names></name><name><surname>Brazier</surname><given-names>AJ</given-names></name><name><surname>Andisi</surname><given-names>C</given-names></name><name><surname>Janes</surname><given-names>JH</given-names></name><name><surname>Soma</surname><given-names>VL</given-names></name><etal/></person-group><article-title>A restricted subset of var genes mediates adherence of <italic>Plasmodium falciparum</italic>-infected erythrocytes to brain endothelial cells</article-title><source>Proc Natl Acad Sci</source><year>2012</year><volume>109</volume><fpage>E1782</fpage><lpage>E1790</lpage><pub-id pub-id-type="doi">10.1073/pnas.1120534109</pub-id><?supplied-pmid 22619321?><pub-id pub-id-type="pmid">22619321</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claessens</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>Y</given-names></name><name><surname>Ghumra</surname><given-names>A</given-names></name><name><surname>Lindergard</surname><given-names>G</given-names></name><name><surname>Buchan</surname><given-names>CC</given-names></name><name><surname>Andisi</surname><given-names>C</given-names></name><etal/></person-group><article-title>A subset of group A-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells</article-title><source>Proc Natl Acad Sci</source><year>2012</year><volume>109</volume><fpage>E1772</fpage><lpage>E1781</lpage><pub-id pub-id-type="doi">10.1073/pnas.1120461109</pub-id><?supplied-pmid 22619330?><pub-id pub-id-type="pmid">22619330</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Magistrado</surname><given-names>P</given-names></name><name><surname>Hermsen</surname><given-names>CC</given-names></name><name><surname>Salanti</surname><given-names>A</given-names></name><name><surname>Jensen</surname><given-names>AT</given-names></name><name><surname>Sauerwein</surname><given-names>R</given-names></name><etal/></person-group><article-title>Expression of <italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 in experimentally infected humans</article-title><source>Malar J.</source><year>2005</year><volume>4</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-4-21</pub-id><?supplied-pmid 15857512?><pub-id pub-id-type="pmid">15857512</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magistrado</surname><given-names>PA</given-names></name><name><surname>Lusingu</surname><given-names>J</given-names></name><name><surname>Vestergaard</surname><given-names>LS</given-names></name><name><surname>Lemnge</surname><given-names>M</given-names></name><name><surname>Lavstsen</surname><given-names>T</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><etal/></person-group><article-title>Immunoglobulin G antibody reactivity to a group A <italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 and protection from <italic>P. falciparum</italic> malaria</article-title><source>Infect Immun</source><year>2007</year><volume>75</volume><fpage>2415</fpage><lpage>2420</lpage><pub-id pub-id-type="doi">10.1128/IAI.00951-06</pub-id><?supplied-pmid 17283085?><pub-id pub-id-type="pmid">17283085</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>SS</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>CW</given-names></name><name><surname>Petersen</surname><given-names>JE</given-names></name><name><surname>Kraft</surname><given-names>M</given-names></name><name><surname>Lusingu</surname><given-names>JP</given-names></name><etal/></person-group><article-title><italic>Plasmodium falciparum</italic> expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e69117</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0069117</pub-id><?supplied-pmid 23874884?><pub-id pub-id-type="pmid">23874884</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combes</surname><given-names>V</given-names></name><name><surname>Taylor</surname><given-names>TE</given-names></name><name><surname>Juhan-Vague</surname><given-names>I</given-names></name><name><surname>Mege</surname><given-names>JL</given-names></name><name><surname>Mwenechanya</surname><given-names>J</given-names></name><name><surname>Tembo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma</article-title><source>JAMA</source><year>2004</year><volume>291</volume><fpage>2542</fpage><lpage>2544</lpage><?supplied-pmid 15173142?><pub-id pub-id-type="pmid">15173142</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faille</surname><given-names>D</given-names></name><name><surname>Combes</surname><given-names>V</given-names></name><name><surname>Mitchell</surname><given-names>AJ</given-names></name><name><surname>Fontaine</surname><given-names>A</given-names></name><name><surname>Juhan-Vague</surname><given-names>I</given-names></name><name><surname>Alessi</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium</article-title><source>FASEB J.</source><year>2009</year><volume>23</volume><fpage>3449</fpage><lpage>3458</lpage><pub-id pub-id-type="doi">10.1096/fj.09-135822</pub-id><?supplied-pmid 19535685?><pub-id pub-id-type="pmid">19535685</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heddini</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Obiero</surname><given-names>J</given-names></name><name><surname>Kai</surname><given-names>O</given-names></name><name><surname>Fernandez</surname><given-names>V</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><etal/></person-group><article-title>Binding of <italic>Plasmodium falciparum</italic>-infected erythrocytes to soluble platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): frequent recognition by clinical isolates</article-title><source>Am J Trop Med Hyg</source><year>2001</year><volume>65</volume><fpage>47</fpage><lpage>51</lpage><?supplied-pmid 11504407?><pub-id pub-id-type="pmid">11504407</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karyana</surname><given-names>M</given-names></name><name><surname>Burdarm</surname><given-names>L</given-names></name><name><surname>Yeung</surname><given-names>S</given-names></name><name><surname>Kenangalem</surname><given-names>E</given-names></name><name><surname>Wariker</surname><given-names>N</given-names></name><name><surname>Maristela</surname><given-names>R</given-names></name><etal/></person-group><article-title>Malaria morbidity in Papua Indonesia, an area with multidrug resistant <italic>Plasmodium vivax</italic> and <italic>Plasmodium falciparum</italic></article-title><source>Malar J.</source><year>2008</year><volume>7</volume><fpage>148</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-7-148</pub-id><?supplied-pmid 18673572?><pub-id pub-id-type="pmid">18673572</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>TW</given-names></name><name><surname>Lampah</surname><given-names>DA</given-names></name><name><surname>Kenangalem</surname><given-names>E</given-names></name><name><surname>Tjitra</surname><given-names>E</given-names></name><name><surname>Price</surname><given-names>RN</given-names></name><name><surname>Anstey</surname><given-names>NM</given-names></name></person-group><article-title>Impaired skeletal muscle microvascular function and increased skeletal muscle oxygen consumption in severe falciparum malaria</article-title><source>J Infect Dis</source><year>2013</year><volume>207</volume><fpage>528</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis692</pub-id><?supplied-pmid 23162136?><pub-id pub-id-type="pmid">23162136</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tjitra</surname><given-names>E</given-names></name><name><surname>Suprianto</surname><given-names>S</given-names></name><name><surname>Currie</surname><given-names>BJ</given-names></name><name><surname>Morris</surname><given-names>PS</given-names></name><name><surname>Saunders</surname><given-names>JR</given-names></name><name><surname>Anstey</surname><given-names>NM</given-names></name></person-group><article-title>Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia</article-title><source>Am J Trop Med Hyg</source><year>2001</year><volume>65</volume><fpage>309</fpage><lpage>317</lpage><?supplied-pmid 11693875?><pub-id pub-id-type="pmid">11693875</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>e108</fpage><pub-id pub-id-type="doi">10.1093/nar/gkt214</pub-id><?supplied-pmid 23558742?><pub-id pub-id-type="pmid">23558742</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crusoe</surname><given-names>M</given-names></name><name><surname>Edvenson</surname><given-names>G</given-names></name><name><surname>Fish</surname><given-names>J</given-names></name><name><surname>Howe</surname><given-names>Adina</given-names></name><name><surname>McDonald</surname><given-names>E</given-names></name><etal/></person-group><article-title>The khmer software package: enabling efficient sequence analysis</article-title><source>Figshare</source><year>2014</year></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>MH</given-names></name><name><surname>Zerbino</surname><given-names>DR</given-names></name><name><surname>Vingron</surname><given-names>M</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name></person-group><article-title>Oases: robust de novo RNA-seq assembly across the dynamic range of expression levels</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>1086</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts094</pub-id><?supplied-pmid 22368243?><pub-id pub-id-type="pmid">22368243</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Madan</surname><given-names>A</given-names></name></person-group><article-title>CAP3: a DNA sequence assembly program</article-title><source>Genome Res</source><year>1999</year><volume>9</volume><fpage>868</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1101/gr.9.9.868</pub-id><?supplied-pmid 10508846?><pub-id pub-id-type="pmid">10508846</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cham</surname><given-names>GK</given-names></name><name><surname>Kurtis</surname><given-names>J</given-names></name><name><surname>Lusingu</surname><given-names>J</given-names></name><name><surname>Theander</surname><given-names>TG</given-names></name><name><surname>Jensen</surname><given-names>AT</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name></person-group><article-title>A semi-automated multiplex high-throughput assay for measuring IgG antibodies against <italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma</article-title><source>Malar J.</source><year>2008</year><volume>7</volume><fpage>108</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-7-108</pub-id><?supplied-pmid 18549480?><pub-id pub-id-type="pmid">18549480</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuboi</surname><given-names>T</given-names></name><name><surname>Takeo</surname><given-names>S</given-names></name><name><surname>Sawasaki</surname><given-names>T</given-names></name><name><surname>Torii</surname><given-names>M</given-names></name><name><surname>Endo</surname><given-names>Y</given-names></name></person-group><article-title>An efficient approach to the production of vaccines against the malaria parasite</article-title><source>Methods Mol Biol</source><year>2010</year><volume>607</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1007/978-1-60327-331-2_8</pub-id><?supplied-pmid 20204850?><pub-id pub-id-type="pmid">20204850</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuboi</surname><given-names>T</given-names></name><name><surname>Takeo</surname><given-names>S</given-names></name><name><surname>Iriko</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Tsuchimochi</surname><given-names>M</given-names></name><name><surname>Matsuda</surname><given-names>S</given-names></name><etal/></person-group><article-title>Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates</article-title><source>Infect Immun</source><year>2008</year><volume>76</volume><fpage>1702</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1128/IAI.01539-07</pub-id><?supplied-pmid 18268027?><pub-id pub-id-type="pmid">18268027</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delucchi</surname><given-names>KL</given-names></name><name><surname>Bostrom</surname><given-names>A</given-names></name></person-group><article-title>Methods for analysis of skewed data distributions in psychiatric clinical studies: working with many zero values</article-title><source>Am J Psychiatry</source><year>2004</year><volume>161</volume><fpage>1159</fpage><lpage>1168</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.161.7.1159</pub-id><?supplied-pmid 15229044?><pub-id pub-id-type="pmid">15229044</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>BA</given-names></name><name><surname>Welch</surname><given-names>TL</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name></person-group><article-title>Widespread functional specialization of <italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome</article-title><source>Mol Microbiol</source><year>2003</year><volume>47</volume><fpage>1265</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03378.x</pub-id><?supplied-pmid 12603733?><pub-id pub-id-type="pmid">12603733</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>MF</given-names></name><name><surname>Caragounis</surname><given-names>A</given-names></name><name><surname>Noviyanti</surname><given-names>R</given-names></name><name><surname>Kyriacou</surname><given-names>HM</given-names></name><name><surname>Choong</surname><given-names>EK</given-names></name><name><surname>Boysen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Transcribed <italic>var</italic> genes associated with placental malaria in Malawian women</article-title><source>Infect Immun</source><year>2006</year><volume>74</volume><fpage>4875</fpage><lpage>4883</lpage><pub-id pub-id-type="doi">10.1128/IAI.01978-05</pub-id><?supplied-pmid 16861676?><pub-id pub-id-type="pmid">16861676</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Flick</surname><given-names>K</given-names></name><name><surname>Kremsner</surname><given-names>P</given-names></name><name><surname>Fernandez</surname><given-names>V</given-names></name><name><surname>Wahlgren</surname><given-names>M</given-names></name></person-group><article-title>The 3D7<italic>var</italic>5.2 (<italic>var</italic> COMMON) type <italic>var</italic> gene family is commonly expressed in non-placental <italic>Plasmodium falciparum</italic> malaria</article-title><source>Mol Biochem Parasitol</source><year>2003</year><volume>127</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/S0166-6851(03)00004-5</pub-id><?supplied-pmid 12672527?><pub-id pub-id-type="pmid">12672527</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>MF</given-names></name><name><surname>Brown</surname><given-names>GV</given-names></name><name><surname>Basuki</surname><given-names>W</given-names></name><name><surname>Krejany</surname><given-names>EO</given-names></name><name><surname>Noviyanti</surname><given-names>R</given-names></name><name><surname>Cowman</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Transcription of multiple <italic>var</italic> genes by individual, trophozoite-stage <italic>Plasmodium falciparum</italic> cells expressing a chondroitin sulphate A binding phenotype</article-title><source>Mol Microbiol</source><year>2002</year><volume>43</volume><fpage>1285</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.02822.x</pub-id><?supplied-pmid 11918813?><pub-id pub-id-type="pmid">11918813</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyes</surname><given-names>SA</given-names></name><name><surname>Christodoulou</surname><given-names>Z</given-names></name><name><surname>Raza</surname><given-names>A</given-names></name><name><surname>Horrocks</surname><given-names>P</given-names></name><name><surname>Pinches</surname><given-names>R</given-names></name><name><surname>Rowe</surname><given-names>JA</given-names></name><etal/></person-group><article-title>A well-conserved <italic>Plasmodium falciparum var</italic> gene shows an unusual stage-specific transcript pattern</article-title><source>Mol Microbiol</source><year>2003</year><volume>48</volume><fpage>1339</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03505.x</pub-id><?supplied-pmid 12787360?><pub-id pub-id-type="pmid">12787360</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janes</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>CP</given-names></name><name><surname>Levin-Edens</surname><given-names>E</given-names></name><name><surname>Vigan-Womas</surname><given-names>I</given-names></name><name><surname>Guillotte</surname><given-names>M</given-names></name><name><surname>Melcher</surname><given-names>M</given-names></name><etal/></person-group><article-title>Investigating the host binding signature on the <italic>Plasmodium falciparum</italic> PfEMP1 protein family</article-title><source>PLoS Pathog</source><year>2011</year><volume>7</volume><fpage>e1002032</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002032</pub-id><?supplied-pmid 21573138?><pub-id pub-id-type="pmid">21573138</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengtsson</surname><given-names>A</given-names></name><name><surname>Joergensen</surname><given-names>L</given-names></name><name><surname>Rask</surname><given-names>TS</given-names></name><name><surname>Olsen</surname><given-names>RW</given-names></name><name><surname>Andersen</surname><given-names>MA</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><etal/></person-group><article-title>A novel domain cassette identifies <italic>Plasmodium falciparum</italic> PfEMP1 proteins binding ICAM-1 and is a target of cross-reactive, adhesion-inhibitory antibodies</article-title><source>J Immunol.</source><year>2013</year><volume>190</volume><fpage>240</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202578</pub-id><?supplied-pmid 23209327?><pub-id pub-id-type="pmid">23209327</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>J</given-names></name><name><surname>Mphande</surname><given-names>FA</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><name><surname>Rogerson</surname><given-names>SJ</given-names></name><name><surname>Taylor</surname><given-names>TE</given-names></name><etal/></person-group><article-title>Differential var gene expression in the organs of patients dying of falciparum malaria</article-title><source>Mol Microbiol</source><year>2007</year><volume>65</volume><fpage>959</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.05837.x</pub-id><?supplied-pmid 17617167?><pub-id pub-id-type="pmid">17617167</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cham</surname><given-names>GK</given-names></name><name><surname>Turner</surname><given-names>L</given-names></name><name><surname>Kurtis</surname><given-names>JD</given-names></name><name><surname>Mutabingwa</surname><given-names>T</given-names></name><name><surname>Fried</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Hierarchical, domain type-specific acquisition of antibodies to <italic>Plasmodium falciparum</italic> erythrocyte membrane protein 1 in Tanzanian children</article-title><source>Infect Immun</source><year>2010</year><volume>78</volume><fpage>4653</fpage><lpage>4659</lpage><pub-id pub-id-type="doi">10.1128/IAI.00593-10</pub-id><?supplied-pmid 20823214?><pub-id pub-id-type="pmid">20823214</pub-id></element-citation></ref></ref-list></back></article>